DNA helix background
Lumnora logoSpin-off of Politecnico di Milano | CNR

Picture the Invisible

Unlocking precision medicine through extracellular vesicles.

Our Vision?

Becoming the golden standard for EV characterization in research and clinical applications.

How We Do It?

Through next-generation imaging flow cytometry delivering unprecedented EV analysis.

Highlights

Accuracy

Single Vesicle Fidelity

Structured Illumination and Lightsheet microscopy for reliable single vesicle analysis,phenotyping and biomarker colocalization.

Scalability

Optofluidic Integration in Single Glass Chip

Femtosecond laser fabricated optofluidic components in a single glass chip enable alignment-free, compact, and scalable design.

Automation

Throughput and End-to-end Orchestration

Automated microfluidic control for high-throughput data acquisition and AI-powered real-time analysis.

Mission

Turning vesicle messaging into routine diagnostics

Lumnora delivers a compact imaging flow cytometer that listens to the extracellular vesicle traffic of every cell. In one automated run, labs gain the sharpness of super-resolution microscopy, the sensitivity of light-sheet microscopy, the throughput of cytometry, and AI-ready datasets that translate straight into clinical programs.

  • EV

    Biology decoded

    Single vesicles become rich biomarker sources, not noisy background.

  • AI

    Insight on demand

    Automated analytics turn imaging runs into decision-ready dashboards.

  • AIO

    All-in-one instrument

    First platform to combine spatial and molecular information for end-to-end EV characterization.

Advanced imaging station analyzing extracellular vesicles

Technology

Platform built for clinical adoption

Photonics, microfluidics, and AI collapse into one workflow so teams move from raw biofluids to vesicle signatures in a single session.

🔬

Advanced imaging

Light-sheet microscopy captures parallel EVs and 3D cell structures, while structured illumination preserves nanoscale detail across heterogeneous samples.

💧

Microfluidic orchestration

Automated sample handling keeps vesicle streams aligned without manual intervention.

🤖

AI decision engine

Edge AI delivers instant annotations and orchestrates downstream decisions.

Research proof points

Validated technology for high clinical impact

Strategic partnerships convert optical breakthroughs into validation data and regulatory-ready workflows.

Lumnora mark

Validated proof-of-concept

Four papers on technology and multi-cell applications, backed by two key patents.

Lumnora mark

Partner-driven roadmap

Prototype adaptation for EV analysis in a user-oriented development. Early collaborations provide fast feedback to finalize a platform for real clinical needs.

Lumnora mark

Regulatory runway

Long-term roadmap toward clinical adaptation, building the evidence and compliance needed for medical device certification.

Researchers partnering with Lumnora

Team

Leadership & Advisors

Operational TeamPhD Physics
Giulio Coccia

Giulio Coccia

CEO

Driving force behind Lumnora: uncovered the market opportunity, assembled the team, and built a strong early network in the EV field.

Operational TeamMSc Biomedical Eng
Niccolò Rondelli

Niccolò Rondelli

CTO

Bridging biology and AI: leads tech development with a background in EVs, biomedical engineering, and AI.

Operational TeamMSc Mgmt Eng
Federico Nobili

Federico Nobili

CFO

Actively involved in entrepreneurial and investment projects alongside his financial background.

Scientific AdvisorsPhD Physics
Andrea Bassi

Andrea Bassi

Microscopy

Politecnico di Milano professor steering optical architecture and integration.

Scientific AdvisorsPhD Electronic Eng
Francesca Bragheri

Francesca Bragheri

Photonics

CNR researcher advancing the optofluidic chip and photonic miniaturisation.

Scientific AdvisorsPhD Physics
Petra Paiè

Petra Paiè

Microfluidics

Politecnico associate professor leading microfluidic automation and reliability.

Contact

Schedule a deep dive

Share your diligence focus. We circulate the data room, roadmap, and connect you with technical leadership.

  • Investors: Access the business model and long-term roadmap.
  • Researchers: Explore pilot opportunities and joint assay development.
  • Clinicians: Evaluate how Lumnora fits into your evidence-generation pipeline.

Ready to dig into the data room or book time with the team? Drop us an email and we will reply within two business days.

Email info@lumnora.com

Attach your brief or diligence checklist if available.